Vascular endothelial growth factor as a risk predictor of thromboembolic complications in patients with orthopaedic profile
Objective: to determine the risk of thromboembolic complications in orthopaedic patients. Material and methods. A survey of 151 patients who had undergone total endoprosthesis of large joints of the lower extremities, aged 25-68, under treatment in Saratov Scientific Research Institute of Orthopedic...
Main Authors: | Vorobeva I.S., Nikitina V.V., Gladilin G.P., Ivanenko I.L. |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Saratov State Medical University
2016-09-01
|
Series: | Саратовский научно-медицинский журнал |
Subjects: | |
Online Access: | http://www.ssmj.ru/system/files/2016_03_354-358.pdf |
Similar Items
-
Proposal of the Definition for COVID-19-Associated Coagulopathy
by: Toshiaki Iba, et al.
Published: (2021-01-01) -
Modulation of vascular endothelial growth factor receptor affinity by neuropilin-1 and heparan sulfate proteoglycans
by: Teran, Madelane
Published: (2016) -
Extra-vascular type of oral intravascular papillary endothelial hyperplasia (Masson′s tumor) of lower lip: A case report and review of the literature
by: G S Sarode, et al.
Published: (2015-01-01) -
Heparininduced thrombocytopenia in patients with venous thromboembolic complications – clinical cases and review of the literature
by: N. Yu. Semigolovskii, et al.
Published: (2018-04-01) -
The Coagulopathy Bleeding in Disseminated Intravascular Coagulation. Therapy by Heparin and Treatment Plasmapheresis
by: Kurgan M., et al.
Published: (2015-12-01)